Medpace (NSDQ:MEDP) shares surged today after the contract research organization posted second-quarter numbers that topped the consensus forecast. Cincinnati-based Medpace reported profits of $27.5 million, or 73¢ per share, on sales of $214.1 million for the three months ended June 30, representing a bottom-line gain of 65.7% on sales growth of 25.8% compared with Q2 […]
Medpace
Medpace prices $248m secondary offering
Medpace (NSDQ:MEDP) today priced an upcoming secondary offering which could bring in up to approximately $247.5 million. In the offering, the Cincinnati-based company said that investment funds affiliated with Cinven Capital Management will offer approximately 4.5 million shares of its stock at a price of $55 per share. The offering also includes a 30-day underwriter’s option […]
Medpace stock down 18% after CEO talks of ‘permanent or increasing margin headwind’
The stock of clinical contract research organization Medpace (Nasdaq: MEDP) took a hit today after the company’s CEO Dr. August Troendle told analysts that the company is facing a “relatively permanent or increasing margin headwind in the next few years.” Medpace’s stock was down $7.02 per share, or nearly 18%, to $32.02 by the close of trading. […]
Medpace prices $126m secondary offering
Medpace (NSDQ:MEDP) yesterday said affiliates of Cinven Capital Management are launching a secondary offering of 4 million shares of its common stock at $31.50 per share, for gross proceeds of $126 million – not including an underwriter’s option worth another $18.9 million. The offering includes a 30-day underwriters option to purchase an additional 600,000 shares, Cincinnati-based […]
CRO Medpace prepares secondary offering
Contract research organization Medpace (NSDQ:MEDP) yesterday announced an upcoming secondary offering of 4 million shares, which could bring in as much as $137 million given current share price for majority shareholder Cinven Capital. In addition to the initial 4 million shares, the offering includes a 30-day underwriters option to purchase an additional 600,000 shares, totaling more than […]
Medpace IPO drums up $185m
Contract research organization Medpace (NSDQ:MEDP) said yesterday that its initial public offering closed after raising more than $185 million, including an underwriter’s over-allotment that added more than $24 million to the IPO. Cincinnati-based Medpace said it floated 8.05 million shares at $23 apiece, including the 1.05-million-share over-allotment, netting about $173.6 million for the CRO. The proceeds are earmarked […]
Medpace prices $161m IPO
Contract research organization Medpace today released the pricing for its initial public offering, looking to float 7 million shares at between $20 and $23 per share, which will bring in between $140 and $161 million. Private equity shop Cinven paid CCMP Capital Advisors $921.3 million for Cincinnati-based Medpace in 2014. The company originally registered for the […]
CRO Medpace registers $150m IPO
Contract research organization Medpace last week registered for a $150 million initial public offering it plans to use to pay down some of its debt. Private equity shop Cinven paid CCMP Capital Advisors $921.3 million for Cincinnati-based Medpace in 2014. Medpace filed confidentially for the IPO back in March. Jefferies and Credit Suisse are joint book-runners for […]